Researchers from Stanford University explain that patients on dialysis represent an important population to study general COVID-19 seroprevalence. These patients already undergo routine, monthly laboratory studies and represent ...
Sep 26, 2020
1
96
Authors of a review of policies, based on the experiences of nine high-income countries and regions' easing of lockdown measures, published in The Lancet journal, are urging governments to consider five key factors in lockdown ...
Sep 25, 2020
0
2
Public confidence in vaccines varies widely between countries and regions around the world, with signs that public trust may be improving in parts of Europe, whilst several countries experiencing political instability and ...
Sep 11, 2020
0
3
New modelling research, published in The Lancet Global Health journal, estimates that it could cost low- and middle-income countries (LMICs) around US$52 billion (equivalent to US$8.60 per person) over four weeks to provide ...
Sep 10, 2020
0
1
Over the next two weeks, The Lancet will be publishing two reports calling for urgent global action on non-communicable diseases (NCDs).
Sep 4, 2020
0
2
Effective contact tracing and epidemic control measures are essential for safe opening of schools during COVID-19 pandemic, according to two studies published simultaneously in The Lancet Child & Adolescent Health journal.
Aug 4, 2020
0
2
Modifying 12 risk factors over the lifecourse could delay or prevent 40% of dementia cases, according to an update to The Lancet Commission on dementia prevention, intervention, and care, which is being presented at the Alzheimer's ...
Jul 30, 2020
0
620
Web-based surveillance of the global spread of SARS-CoV-2 (the virus that causes COVID-19) during the first 11 weeks of the outbreak (Dec 31, 2019, to March 10, 2020), reveals that three-quarters (75/99) of affected countries ...
Jul 30, 2020
0
113
Disruption to cancer diagnosis services (referrals and routine screening) and people avoiding healthcare because of the COVID-19 pandemic could result in around 3,500 potentially avoidable deaths from the four main cancers ...
Jul 21, 2020
0
29
A phase 2 trial of an Ad5 vectored COVID-19 vaccine candidate, conducted in China, has found that the vaccine is safe and induces an immune response, according to new research published in The Lancet.
Jul 20, 2020
0
1150
